Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab with CVP and Interferon for Newly Diagnosed Follicular Lymphoma
NCT00842114Phase 2Completed
- Sponsor
- Fundación Leucemia y Linfoma
- Start
- Feb 2006
- Primary completion
- Mar 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in follicular lymphoma (FL), sponsored by Fundación Leucemia y Linfoma. Started Feb 2006; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00842114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00842114.